Abstract
Periodontal disease affects nearly half of the global population, posing a significant public health challenge. While antimicrobial agents remain the standard treatment, the growing concern of antimicrobial resistance among periodontal pathogens necessitates the exploration of alternative therapeutic strategies. This study presents ellagic acid-functionalized lignin nanoparticles (LeLNPs) as a novel and sustainable approach for periodontal therapy. Lignin was functionalized with ellagic acid using laccase-mediated oxidation, followed by high-shear homogenization to generate LeLNPs with a slightly uniform nanoscale size (average diameter <58 nm) and enhanced phenolic content. The nanoparticles exhibited strong antimicrobial activity against periodontal pathogens, with a minimum inhibitory concentration (MIC) of 0.625 mg/L. Mechanistic evaluations revealed that LeLNPs disrupt bacterial membrane integrity, elevate reactive oxygen species (ROS) levels, and reduce metabolic activity, impairing microbial survival. Given their potent antimicrobial efficacy, natural biocompatibility, and eco-friendly properties, LeLNPs hold promise as an innovative therapeutic agent for periodontal disease. Their potential application in oral healthcare products, such as toothpaste and mouthwash, underscores their relevance as a sustainable solution for dental health.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
